Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thyroid Eye Disease, TED”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07308964
What this trial is testing

Comparison of the Efficacy and Safety of 4 vs. 8 Treatments With Tepezza (Teprotumumab) for Thyroid Eye Disease

Who this might be right for
Thyroid Eye DiseaseThyroid Eye Disease, TEDThyroid Eye Disease (TED)
Sheba Medical Center 40
Post-approval studies (Phase 4)Looking for participantsNCT07152392
What this trial is testing

Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAO

Who this might be right for
Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT06401044
What this trial is testing

AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Amgen 88
Large-scale testing (Phase 3)Looking for participantsNCT06112340
What this trial is testing

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye DiseaseGraves OrbitopathyEndocrine System Diseases+9 more
Sling Therapeutics, Inc. 75
Large-scale testing (Phase 3)WithdrawnNCT02393183
What this trial is testing

The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Iran University of Medical Sciences
Early research (Phase 1)Study completedNCT07142642
What this trial is testing

Evaluate Pharmacokinetics, Safety, and Tolerability of Teprotumumab (AMG 632) Administered Intravenously in Healthy Chinese Participants

Who this might be right for
Healthy Volunteers
Amgen 20
Large-scale testing (Phase 3)Looking for participantsNCT05517447
What this trial is testing

Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Immunovant Sciences GmbH 180
Testing effectiveness (Phase 2)Study completedNCT01868997
What this trial is testing

Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease

Who this might be right for
Thyroid Associated OphthalmopathiesThyroid-Associated Ophthalmopathy
Amgen 88
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06769984
What this trial is testing

SCTT11 in Healthy Participants and Participants with Thyroid Eye Disease.

Who this might be right for
TED
Sinocelltech Ltd. 100
Large-scale testing (Phase 3)Active Not RecruitingNCT06812325
What this trial is testing

A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease (TED)
Viridian Therapeutics, Inc. 321
Large-scale testing (Phase 3)UnknownNCT05015127
What this trial is testing

Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease

Who this might be right for
Thyroid Ophthalmopathy
Harbour BioMed (Guangzhou) Co. Ltd. 36
Large-scale testing (Phase 3)Active Not RecruitingNCT05276063
What this trial is testing

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye DiseaseGraves OrbitopathyEndocrine System Diseases+9 more
Sling Therapeutics, Inc. 90
Large-scale testing (Phase 3)Not Yet RecruitingNCT07262476
What this trial is testing

Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease (TED)
Minghui Pharmaceutical (Hangzhou) Ltd 258
Post-approval studies (Phase 4)Looking for participantsNCT07152340
What this trial is testing

The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.

Who this might be right for
Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital 64
Testing effectiveness (Phase 2)Study completedNCT05683496
What this trial is testing

Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
ACELYRIN Inc. 31
Large-scale testing (Phase 3)Study completedNCT06021054
What this trial is testing

An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) (THRIVE-2)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 188
Not applicableStudy completedNCT04433936
What this trial is testing

Corneal Tomographic Parameters in TGD

Who this might be right for
KeratoconusCorneal EctasiaThyroid Eye Disease
Ameera Gamal Abdelhameed 100
Large-scale testing (Phase 3)Study completedNCT05517421
What this trial is testing

Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Immunovant Sciences GmbH 114
Large-scale testing (Phase 3)Ended earlyNCT04737330
What this trial is testing

The Efficacy and Safety of Secukinumab 300 mg in Patients With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye DiseaseGraves Orbitopathy
Novartis Pharmaceuticals 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07404111
What this trial is testing

VV-14305 for the Treatment of Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease (TED)
Kriya Therapeutics, Inc. 110
Load More Results